EndoQuest RoboticsNot yet claimed

About EndoQuest Robotics

EndoQuest Robotics, Inc. is a Houston, Texas medical device company developing a flexible robotic system for endoluminal surgery — operating inside the body’s natural passages, through the mouth or anus, or through a single transumbilical incision — so that gastrointestinal procedures can be performed with no external scars. Founded as ColubrisMX and rebranded to EndoQuest Robotics in June 2022, the company built its Endoluminal Surgical (ELS) System to give therapeutic endoscopists and surgeons robotic access, precision and flexibility for upper and lower GI procedures, including endoscopic submucosal dissection of complex colorectal lesions that might otherwise require invasive surgery such as colectomy.

The U.S. FDA granted an Investigational Device Exemption in December 2024 for the pivotal PARADIGM trial in robotic colorectal surgery at five U.S. centres, and the company reported the first procedures in that trial in 2025; the system remains investigational and is not cleared for commercial sale in the United States. In 2025 EndoQuest also announced work with NVIDIA to bring AI vision (IGX Thor) into its next-generation platform. The privately held company is a pure-play bet on scarless, natural-orifice robotic surgery, a segment where it claims the first endoluminal robotic surgical system.

Products & services

• EndoQuest Endoluminal Surgical (ELS) System — flexible robotic platform for endoluminal and single-incision surgery through natural orifices (investigational; FDA IDE granted December 2024 for the pivotal PARADIGM colorectal study)
• Robotic endoscopic submucosal dissection (ESD) capability for complex rectal and colonic lesions
• Next-generation platform development with AI vision (NVIDIA IGX Thor collaboration announced 2025)

Questions partners ask

GlobleMatch Trust Signals

A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.

Public information coverage	8 of 9 fields on the standard profile could be filled from public sources. This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself.
Last verified	6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed.

Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.

Sources & verification

• Company website — endoquestrobotics.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
• Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.

Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.

Related companies

More in Robotics & hardware: Wandercraft (self-balancing robotic mobility systems, France) · Dyna Robotics (robot foundation models and general-purpose commercial robots, United States) · Collaborative Robotics (mobile manipulators / autonomous mobile robots for material handling, United States)

Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.